China-based laser diagnosis and treatment specialist Shenzhen Vivolight Medical Device & Technology Co., Ltd reportedly raised over RMB 100 million (USD 14.2 million) in a Series D1 financing round. The round was led by Huajin Capital and Fosun Health Fund, with participation from Kaihe Capital, Sequoia China, and CASSTAR. The proceeds will be used for the development and clinical studies of laser therapy products in the cranial, peripheral, and ophthalmic fields.
Company Background and Core Technologies
Founded in 2012, Vivolight is a leading specialist in laser diagnosis and treatment, boasting core technology platforms in ultrafast laser, fiber optic catheter, and image processing. The company holds over 140 intellectual properties and owns the most comprehensive OCT (Optical Coherence Tomography) product pipelines in China. This funding round is expected to further enhance Vivolight’s position in the laser medical device market.-Fineline Info & Tech
